loader

World Tenders & Procurement Opportunities

Acquisition of a combined hexavalent vaccine against diphtheria-tetanus-acellular pertussis, injectable poliomyelitis, haemophilus influenzae type B and hepatitis B (DTPa-VPI-HIB-VHB), for the vaccination programme of the Basque Autonomous Community, under the terms set out in the specific technical specifications.

World Biggest Tenders Source

This tender with title Acquisition of a combined hexavalent vaccine against diphtheria-tetanus-acellular pertussis, injectable poliomyelitis, haemophilus influenzae type B and hepatitis B (DTPa-VPI-HIB-VHB), for the vaccination programme of the Basque Autonomous Community, under the terms set out in the specific technical specifications. has been published on Bidding Source portal dated 04 Jul 2024 for the country of Spain. It has been categorized on Injectable solutions & Polio vaccines & Pharmaceutical products & Diphtheria-tetanus vaccines & Vaccines & Hepatitis B vaccines & Influenza vaccines & Diphtheria-pertussis-tetanus vaccines. For similar tenders you can see tenders mentioned below of this page.

General Information

Acquisition of a combined hexavalent vaccine against diphtheria-tetanus-acellular pertussis, injectable poliomyelitis, haemophilus influenzae type B and hepatitis B (DTPa-VPI-HIB-VHB), for the vaccination programme of the Basque Autonomous Community, under the terms set out in the specific technical specifications.
Invitation for Bids
Spain
4 Jul 2024
29 Jul 2024
English
Injectable solutions , Polio vaccines , Pharmaceutical products , Diphtheria-tetanus vaccines , Vaccines , Hepatitis B vaccines , Influenza vaccines , Diphtheria-pertussis-tetanus vaccines

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Supply of the exclusive drug: Tofersen (QALSODY). - 624539 -- <b>Contract Value: 2 059 260,41 EUR</b> Spain Awarded - Contract based on a framework agreement for the supply of doses of the monoclonal antibody against respiratory syncytial virus (batch 24) for the period 2026-2027 - 623584 -- <b>Contract Value: 5 600 000,00 EUR</b> Spain Awarded - Suministro del medicamento exclusivo: Factor IX Recombinante-Eftrenonacog Alfa (ALPROLIX). - 623706 -- <b>Contract Value: 861 120,00 EUR</b> Spain Awarded - Suministro tenof alaf, asoc bictegr/emtric/tenof alaf, aztreonam lisina inh, asoc emtric/rilpivirina/tenof disopr fumar, asoc elvitegr/cobicist/emtric/tenof alaf,asoc elvitegr/cobicist/emtric/tenof di - 622151 -- <b>Contract Value: 13 388 037,45 EUR</b> Spain Awarded - Supply of Ranibizumab (DOE), Octreotide (DOE) suspension and Voretigen neparvovec (DOE) - 628232 -- <b>Contract Value: 8 054 222,08 EUR</b> Spain Awarded - Supply of Chlorhexidine (DOE) and combinations with Chlorhexidine (DOE) - 628990 -- <b>Contract Value: 2 135 515,00 EUR</b> Spain Awarded - Supply of the exclusive drug: Berotralstat (ORLADEYO). - 621288 -- <b>Contract Value: 449 550,00 EUR</b> Spain Awarded - Supply of exclusive medicines Brolucizumab (BEOVU), Everolimus (VOTUBIA), Inclisiran (LEQVIO), Ceritinib (ZYKADIA) and Asciminib (SCEMBLIX) and Gozetotide 68GA (LOCAMETZ). - 622402 -- <b>Contract Value: 840 866,26 EUR</b> Spain Awarded - CONTR 2026 200966 CBAM-1 GRANADA AMC 2204-2025 (578/2025) EXCLUSIVE MEDICINES - 628245 -- <b>Contract Value: 404 357,90 EUR</b> Spain Awarded - Supply of the exclusive drug: Ravulizumab (ULTOMIRIS). - 620013 -- <b>Contract Value: 2 603 215,59 EUR</b> Spain
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans